Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Pharmakon1600-01500838

Base Information Edit
  • Chemical Name:Pharmakon1600-01500838
  • CAS No.:67-97-0
  • Molecular Formula:C27H44O
  • Molecular Weight:384.646
  • Hs Code.:29362990
  • NSC Number:757799
  • Mol file:67-97-0.mol
Pharmakon1600-01500838

Synonyms:SR-05000001559;BSPBio_002408;SCHEMBL267918;HMS2092M12;Pharmakon1600-01500838;CCG-38845;NSC757799;NSC-757799;SBI-0052082.P002;AB00052595_02;SR-05000001559-1;SR-05000001559-2;SR-05000001559-3;SR-05000001559-4

Suppliers and Price of Pharmakon1600-01500838
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Usbiological
  • Vitamin D3
  • 96Tests
  • $ 938.00
  • Usbiological
  • Vitamin D3
  • 1g
  • $ 418.00
  • TRC
  • VitaminD3
  • 5g
  • $ 70.00
  • TRC
  • VitaminD3
  • 1g
  • $ 55.00
  • Tocris
  • 22-Oxacalcitriol ≥95%(HPLC)
  • 1
  • $ 212.00
  • Tocris
  • VitaminD3 ≥98%(HPLC)
  • 50
  • $ 53.00
  • Sigma-Aldrich
  • Vitamin D3 solution 1?mg/mL in ethanol, ampule of 1?mL, certified reference material, Cerilliant?
  • 1 mL
  • $ 77.50
  • Sigma-Aldrich
  • Vitamin D3 solution 1 mg/mL in ethanol, ampule of 1 mL, certified reference material
  • 025-1ml
  • $ 75.10
  • Sigma-Aldrich
  • Cholecalciferol meets USP testing specifications
  • 1g
  • $ 70.30
  • Sigma-Aldrich
  • Cholecalciferol (Vitamin D3) Pharmaceutical Secondary Standard; Certified Reference Material
  • 500mg
  • $ 98.70
Total 305 raw suppliers
Chemical Property of Pharmakon1600-01500838 Edit
Chemical Property:
  • Appearance/Colour:Crystalline 
  • Vapor Pressure:6.16E-12mmHg at 25°C 
  • Melting Point:83-86 °C(lit.) 
  • Refractive Index:1.523 
  • Boiling Point:496.4 °C at 760 mmHg 
  • PKA:14.74±0.20(Predicted) 
  • Flash Point:214.2 °C 
  • PSA:20.23000 
  • Density:0.96 g/cm3 
  • LogP:7.61900 
  • Storage Temp.:2-8°C 
  • Sensitive.:Air & Light Sensitive 
  • Solubility.:Practically insoluble in water, freely soluble in ethanol (96 per cent), soluble in trimethylpentane and in fatty oils. It is sensitive to air, heat and light. Solutions in solvents without an antioxidant are unstable and are to be used immediately. A reversible isomerisation to pre-cholecalciferol takes place in solution, depending on temperature and time. The activity is due to both compounds. 
  • Water Solubility.:<0.1 g/L (20℃) 
  • XLogP3:7.9
  • Hydrogen Bond Donor Count:1
  • Hydrogen Bond Acceptor Count:1
  • Rotatable Bond Count:6
  • Exact Mass:384.339216023
  • Heavy Atom Count:28
  • Complexity:610
Purity/Quality:

99%min *data from raw suppliers

Vitamin D3 *data from reagent suppliers

Safty Information:
  • Pictogram(s): VeryT+,Toxic
  • Hazard Codes:T+,T,Xn,F 
  • Statements: 24/25-26-48/25-23/24/25-20-11-48 
  • Safety Statements: 28-36/37-45-28A-36/37/39-16-7 
MSDS Files:

SDS file from LookChem

Total 1 MSDS from other Authors

Useful:
  • Canonical SMILES:CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C
  • Isomeric SMILES:CC(C)CCCC(C)C1CCC\2C1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C
  • Definition and FDA-Approved Indications Cholecalciferol, also known as vitamin D3, is a dietary supplement prescribed for individuals with vitamin D insufficiency or deficiency. It is FDA-approved for use as a dietary supplement.
  • Mechanism of Action Cholecalciferol is inactive until converted into 25-hydroxyvitamin D3 (25(OH)D3) in the liver by the enzyme 25-hydroxylase.
  • Synthesis and Metabolism Cholecalciferol can be endogenously synthesized in the skin through exposure to ultraviolet B radiation or acquired from the diet or supplements. It undergoes a two-step activation process in the liver and kidneys to become biologically active as calcitriol.
  • Physiological Significance Cholecalciferol, being the major form of vitamin D in nature, plays crucial roles in skeletal and extraskeletal functions. It is involved in various diseases due to its physiological actions.
  • Prevalence of Deficiency and Treatment Vitamin D deficiency is significantly prevalent worldwide. Cholecalciferol, along with ergocalciferol and calcifediol, is used for the treatment of vitamin D insufficiency or deficiency.
  • Comparison with Ergocalciferol (Vitamin D2) Cholecalciferol (D3) is distinguished from ergocalciferol (D2), with cholecalciferol being the form primarily found in animals. While both forms can be obtained through diet, cholecalciferol is considered the predominant form of vitamin D in nature.
Technology Process of Pharmakon1600-01500838

There total 141 articles about Pharmakon1600-01500838 which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
With 2,6-di-tert-butyl-4-methyl-phenol; sodium hydroxide; 5-(3-pyridyl)-2,2’-bithiophene; In ethanol; at 80 - 85 ℃; for 3.5h; Temperature; Solvent; Reagent/catalyst; Irradiation;
Refernces Edit

Enantioselective synthesis of a key A-ring intermediate for the preparation of 1α,25-dihydroxyvitamin D3

10.1021/ol102586w

The research focuses on the enantioselective synthesis of a key A-ring intermediate, specifically the R,β-unsaturated aldehyde 1, which is crucial for the preparation of 1α,25-dihydroxyvitamin D3 (calcitriol). The purpose of this study is to develop a novel and efficient approach to synthesize this intermediate, starting from the inexpensive material (R)-carvone, with the potential to create vitamin D3 analogues with modifications at the C-2 position. The research concludes that a new strategy has been successfully developed, which involves 11 steps and yields the desired intermediate in 24% overall yield, with the ene reaction as the key step. This method could be applied to synthesize vitamin D3 analogues with modifications at the C-2 position, which may have increased binding affinity for the vitamin D receptor (VDR) and potent agonistic activity. Key chemicals used in the process include (R)-carvone, LAH, m-CPBA, nitrobenzoate, MOM group, Zn powder, NaI, and active forms of formaldehyde, among others.

Regio- and stereoselective ruthenium-catalyzed hydrovinylation of 1,3-dienes: Application to the generation of a 20(S) steroidal side chain

10.1021/ol030031+

The research describes a regio- and stereoselective ruthenium-catalyzed hydrovinylation of 1,3-dienes, which is a C-C bond-forming reaction that uses ethylene as a cheap feedstock and proceeds in an atom-economical manner. The study focuses on the addition of ethylene to 1,3-dienes and 1-vinylcycloalkenes, catalyzed by two ruthenium complexes, resulting in the formation of 3-methyl-1,4-dienes. The reaction is particularly significant for a steroidal-based 1-vinylcycloalkene, as it yields a product with a 20(S) configuration, which is the opposite of most naturally occurring steroids. The chemicals used in the process include ethylene, 1,3-dienes, 1-vinylcycloalkenes, and two ruthenium catalysts, which are crucial for the selective addition reaction. The study concludes that this hydrovinylation reaction has potential for synthetic applications, especially in generating side chains with the 20(S) configuration, which is valuable for the preparation of nonnatural vitamin D3 analogues and other pharmaceutically relevant compounds.

ON THE LITHIUM DIMETHYLCUPRATE INDUCED CONVERSION OF PROPARGYLIC ESTERS INTO ALLENES USING A STEROIDAL C/D FRAGMENT DERIVED FROM VITAMIN D3 AS A STEREOCHEMICAL PROBE.

10.1016/S0040-4039(00)87437-7

The study investigates the lithium dimethylcuprate induced conversion of propargylic esters into allenes, using a steroidal C/D fragment derived from vitamin D3 as a stereochemical probe. The researchers reacted (CH3)2CuLi with various C-8 propargylic esters derived from Grundmann's ketone, a C/D steroidal fragment originating from vitamin D3, to produce corresponding allenes. The stereocheristry of the resulting allenes indicated a preferred anti 1,3-substitution mode. The study used the C/D ring fragment from Grundmann's ketone as a convenient stereochemical probe for this conversion. The propargylic esters were prepared from Grundmann's ketone through a series of reactions involving tert-BuLi, Ph2Se2, MCPBA oxidation, and hydrolysis. The resulting allenes' stereocheristry was determined by comparing their 'H-NMR spectral data with those of the product of a reaction sequence involving propargylic alcohol and PhSCl. The study concludes that the predominant product in the organocopper promoted conversion of propargylic esters into allenes originates from an anti mode of displacement, regardless of the nature of the leaving group.

Vitamin D3: Synthesis of seco-C-9,11-bisnor-17-methyl-1α,25-dihydroxyvitamin D3 analogues

10.1016/S0960-894X(02)00222-6

The study investigates the synthesis and biological properties of novel D-ring analogues of 1a,25-dihydroxyvitamin D3 (calcitriol). The researchers aimed to develop analogues that can dissociate cell-differentiating effects from calcemic effects, focusing on 17-methyl D-ring analogues lacking the six-membered C-ring. The synthesis involved the Lythgoe coupling of an 8-formyl-D-ring fragment with phosphine oxides, leading to the creation of analogues with both natural (R) and unnatural (S) configurations at C-20. The study evaluated the affinity of these analogues to the vitamin D receptor (VDR) and their antiproliferative activities in various cell lines, finding that some analogues, particularly the hexafluoro analogues, displayed high antiproliferative activity and significant differentiation between antiproliferative and calcemic effects. The chemicals involved included 1a,25-dihydroxyvitamin D3, various phosphine oxides, and a series of ketones used in the synthesis process.

Synthesis of Retiferol RAD1 and RAD2, the Lead Representatives of a New Class of des-CD Analogs of Cholecalciferol

10.1006/bioo.1995.1002

The study investigates the design and total convergent synthesis of new analogs of cholecalciferol (vitamin D) with the CD-ring system replaced by a two-carbon aliphatic spacer. The researchers aimed to simplify the structure of vitamin D-based therapeutics by identifying the essential structural parts responsible for its activity. The key chemicals involved include vitamin D derivatives, such as vitamin D3 and 1α-hydroxyvitamin D3, which serve as precursors for the ring fragments. The chain fragment is derived from S-(-)-β-citronellol, a natural monoterpene. The synthesized compounds, RAD and RAD2, are designed as des-CD analogs of 25-OH-D3 and 1,25-(OH)2D3, respectively, with an unnatural configuration at C-20. The study employs various reagents and conditions, such as imidazole, t-BuMe2SiCl, MCPBA, lithium triethylborohydride, and pyridinium chlorochromate, to achieve the desired modifications and coupling of the ring and chain fragments. The results provide insights into the potential for developing more effective therapeutic agents based on the simplified structure of vitamin D.

Post RFQ for Price